Showing results (361-370 of 387) with videos related to

Sort By:
Pageof 39
Nature|June 30, 2022
Surface-to-space atmospheric waves from Hunga Tonga-Hunga Ha'apai eruptionCorwin J Wright, Neil P Hindley, M Joan Alexander, et al.
Biology|July 29, 2025
The V5-Epitope Tag for Cell Engineering and Its Use in Immunohistochemistry and Quantitative Flow CytometryKatja Fritschle, Marion Mielke, Olga J Seelbach, et al.
Mbio|July 31, 2026
Imaging Staphylococcus aureus biofilms in vivo reveals neutrophil exclusion by PNAG exopolysaccharideRachel M Kratofil, Rehnuma T Sejuty, Trevor E Randall, et al.
European Journal of Immunology|February 11, 2025
ISG15-Dependent Stabilisation of USP18 Is Necessary but Not Sufficient to Regulate Type I Interferon Signalling in HumansAndri Vasou, Katie Nightingale, Vladimíra Cetkovská, et al.
Biorxiv : the Preprint Server for Biology|July 17, 2026
The nucleoside analog CMX521 inhibits coronavirus RNA-dependent RNA polymerase via a two-pronged mechanismAsif Rakib, Calvin Gordon, Thomas K Anderson, et al.
The Pediatric Infectious Disease Journal|November 30, 2006
Salvage therapy with abacavir and other reverse transcriptase inhibitors for human immunodeficiency-associated encephalopathyJesús Saavedra-Lozano, José T Ramos, Francisco Sanz, et al.
Plos Genetics|June 13, 2020
Elevated exopolysaccharide levels in Pseudomonas aeruginosa flagellar mutants have implications for biofilm growth and chronic infectionsJoe J Harrison, Henrik Almblad, Yasuhiko Irie, et al.
The Journal of Biological Chemistry|July 1, 2020
PelX is a UDP-N-acetylglucosamine C4-epimerase involved in Pel polysaccharide-dependent biofilm formationLindsey S Marmont, Gregory B Whitfield, Roland Pfoh, et al.
Journal of Neuro-Oncology|November 21, 2014
Phase 2 study of bosutinib, a Src inhibitor, in adults with recurrent glioblastomaJennie W Taylor, Jorg Dietrich, Elizabeth R Gerstner, et al.
Future Oncology (London, England)|January 8, 2024
CREST: phase III study of sasanlimab and Bacillus Calmette-Guérin for patients with Bacillus Calmette-Guérin-naïve high-risk non-muscle-invasive bladder cancerGary D Steinberg, Neal D Shore, Joan Palou Redorta, et al.
Pageof 39